McKesson Co. (NYSE:MCK) Shares Acquired by Motley Fool Asset Management LLC

Motley Fool Asset Management LLC boosted its holdings in McKesson Co. (NYSE:MCK) by 4.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,951 shares of the company’s stock after acquiring an additional 172 shares during the period. Motley Fool Asset Management LLC’s holdings in McKesson were worth $1,829,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Legacy Financial Group LLC acquired a new position in shares of McKesson during the third quarter valued at approximately $27,000. OFI Invest Asset Management acquired a new position in shares of McKesson during the third quarter valued at approximately $26,000. BKM Wealth Management LLC acquired a new position in shares of McKesson during the fourth quarter valued at approximately $31,000. Avior Wealth Management LLC grew its position in McKesson by 50.0% in the third quarter. Avior Wealth Management LLC now owns 84 shares of the company’s stock worth $37,000 after buying an additional 28 shares during the last quarter. Finally, WASHINGTON TRUST Co grew its position in McKesson by 42.5% in the fourth quarter. WASHINGTON TRUST Co now owns 114 shares of the company’s stock worth $53,000 after buying an additional 34 shares during the last quarter. Institutional investors own 85.07% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have issued reports on MCK shares. Citigroup lifted their price target on shares of McKesson from $530.00 to $575.00 and gave the stock a “buy” rating in a research report on Thursday, February 8th. Argus lifted their price target on shares of McKesson from $510.00 to $570.00 and gave the stock a “buy” rating in a research report on Wednesday, April 10th. SVB Leerink started coverage on shares of McKesson in a research report on Monday, February 26th. They issued an “outperform” rating and a $600.00 price target on the stock. Barclays started coverage on shares of McKesson in a research report on Wednesday, January 3rd. They issued an “overweight” rating and a $537.00 price target on the stock. Finally, UBS Group lifted their price target on shares of McKesson from $575.00 to $620.00 and gave the stock a “buy” rating in a research report on Wednesday, March 6th. Two research analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, McKesson currently has an average rating of “Moderate Buy” and a consensus price target of $533.50.

Insider Transactions at McKesson

In related news, EVP Leann B. Smith sold 186 shares of the stock in a transaction that occurred on Tuesday, February 13th. The shares were sold at an average price of $496.00, for a total value of $92,256.00. Following the transaction, the executive vice president now directly owns 1,511 shares in the company, valued at $749,456. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other McKesson news, CEO Brian S. Tyler sold 3,473 shares of the company’s stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $524.55, for a total value of $1,821,762.15. Following the completion of the sale, the chief executive officer now owns 43,445 shares of the company’s stock, valued at $22,789,074.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Leann B. Smith sold 186 shares of the firm’s stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $496.00, for a total transaction of $92,256.00. Following the completion of the transaction, the executive vice president now directly owns 1,511 shares of the company’s stock, valued at approximately $749,456. The disclosure for this sale can be found here. 0.21% of the stock is owned by company insiders.

McKesson Stock Up 0.6 %

NYSE:MCK traded up $3.43 on Friday, reaching $543.37. The stock had a trading volume of 654,667 shares, compared to its average volume of 686,507. The company has a market capitalization of $71.40 billion, a P/E ratio of 24.62, a price-to-earnings-growth ratio of 1.42 and a beta of 0.45. McKesson Co. has a 1-year low of $352.34 and a 1-year high of $544.81. The stock has a fifty day moving average price of $528.15 and a 200-day moving average price of $489.48.

McKesson (NYSE:MCK) last released its quarterly earnings results on Wednesday, February 7th. The company reported $7.74 EPS for the quarter, beating analysts’ consensus estimates of $7.05 by $0.69. McKesson had a net margin of 0.99% and a negative return on equity of 262.63%. The firm had revenue of $80.90 billion for the quarter, compared to analyst estimates of $77.93 billion. During the same period in the previous year, the business earned $6.90 earnings per share. The company’s revenue for the quarter was up 14.8% compared to the same quarter last year. Sell-side analysts predict that McKesson Co. will post 27.59 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, July 1st. Stockholders of record on Monday, June 3rd will be given a dividend of $0.62 per share. The ex-dividend date is Friday, May 31st. This represents a $2.48 dividend on an annualized basis and a dividend yield of 0.46%. McKesson’s payout ratio is 11.24%.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.